Skip to main content

Outcome Program · Pre-LOI Diligence & Valuation Bridges

Originate off-market targets and stress-test seller claims pre-LOI.

Map fragmented sub-sectors to build bilateral acquisition shortlists, reconcile conflicting market-size reports, isolate buried high-margin subsidiaries, and underwrite the post-close EBITDA and valuation bridge before exclusivity.

The commercial challenge

Seller CIMs overstate addressable markets and mask unit-economic drag.

Deal and corporate development teams waste weeks evaluating auction targets whose headline market growth was driven by price inflation rather than volume, or where commercial databases misstate private-company revenue by multiples. Pre-LOI conviction requires source-tagged market models and outside-in unit economics.

  • Four off-the-shelf industry reports quoting four contradictory market sizes with unstated scope boundaries.
  • High-margin specialty divisions buried inside distressed parent companies with bloated corporate overhead.
  • Commercial databases missing unlisted middle-market roll-up targets or misreporting statutory subsidiary accounts.

What your team receives

Four decision-ready deliverables in one program.

We screen fragmented sectors to originate bilateral roll-up and certified tuck-in targets outside banker auctions, pressure-test seller market claims, customer concentration and backlog durability before exclusivity, and reverse-engineer the margin and unit-economics bridge behind an implied valuation.

  1. 01

    Bilateral target ranking & shortlist

    A multi-factor screen across fragmented industrial, healthcare, defence or services sub-sectors, cross-referencing certifications, capacity and ownership signals.

  2. 02

    Sourced vs. inferred addressable market model

    Bottom-up market sizing reconciling seller claims against agreed geographic and product boundaries, with every cell tagged to its source or formula.

  3. 03

    Standalone carve-out & unit-economics diagnostic

    Outside-in reconstruction of facility headcount, store cohort payback, RevPAR cross-subsidies or subsidiary EBITDA margins.

  4. 04

    Pre-LOI valuation & EBITDA bridge

    A quantified post-close value creation plan sizing working-capital release, pricing/mix lift and SG&A synergies for investment committee review.

Illustrative output

How the executive brief and reconciled databook are structured.

Every cell in the accompanying spreadsheet model is formula-driven and tagged either empirically sourced (with document and page citation) or model-inferred (with stated benchmark assumptions).

Pre-LOI thesis stress-test & valuation bridge · Acquisition targetIllustrative
Illustrative pre-LOI market reconciliation and post-close EBITDA bridge
Diligence workstreamSeller CIM claimReconciled readBridge impactUS$MConfidence
Scoped addressable market (in-geography)$6,200M$4,720M-$1,480Mhigh
Buried medical-device subsidiary standalone EBITDAConsolidated28% margin+$18Mhigh
Boutique cohort expansion & DC automation16% EBITDA20% EBITDA+$150Mhigh
Post-close DIO & payables normalization145d DIO110d DIO+$45Mmedium
Illustrative pre-LOI diligence synthesis; every cell in the underlying data book is tagged as empirically sourced or model-inferred.

Capabilities & starting scopes

Start with one deliverable or run the full outcome loop.

Each outcome program draws on specific steps of the research loop and can be commissioned as a focused starting deliverable or a recurring program.

  1. Map

    How does this market work, and where are the gaps?

    Expose sub-tier supplier chokepoints, sourcing markups and domestic capability gaps.

    You getValue-chain map

  2. Find

    Which ones should we go after first?

    Originate off-market roll-up targets, win-ready defence programs and qualified borrowers.

    You getScorecard and shortlist

  3. Diagnose

    Where is the value, or the risk?

    Quantify trapped working capital, SKU and supplier markups, SG&A bloat and asset-level cost exposure.

    Company diagnosticPeer benchmarkRisk against your framework

    You getDiagnostic and peer benchmark

  4. Plan

    What should we do, and what is it worth?

    Build quantified EBITDA, cash-release, channel-mix and capex-phasing roadmaps.

    You getValue creation plan

How to start

One question, a fixed fee, a first read in days.

Your question
One live question, with the decision it serves.
What comes back
A reviewed answer with a point of view (a ranked shortlist, a diagnostic or a plan), with every source and anything unverified flagged.
The fee
The fee is fixed and agreed before work starts.
The timing
A first read in days, not weeks, then the reviewed brief on the date we agree.

We can provide regular research updates after the first project.

Anonymized proof

What our analysts have uncovered across delivered engagements.

140 → 12

~140 organizations ranked into a 12-target priority shortlist.

Pre-LOI bridge

Implied equity valuation bridges and standalone carve-out reconstructions separating volume growth from channel mix and margin expansion before exclusivity.

Pilot → annual

An institutional investor expanded from a pilot to an annual engagement.

Start with one question

Which target universe or live acquisition thesis should we pressure-test before exclusivity?

Tell us what you’re investigating and when you need an answer. We’ll discuss the scope, inputs and research that would help.

Discuss your project